Proscar

Proscar (Finasteride) is a medicine used to treat benign prostatic hyperplasia (BPH). This is a disease in which the prostate gland becomes enlarged, which can lead to urinary problems and other problems.

Finasteride was developed in the 1980s and has since become one of the most commonly used drugs to treat BPH. It works by inhibiting the enzyme 5-α-reductase, which is involved in the synthesis of dihydrotestosterone (DHT). DHT is the main hormone that causes prostate enlargement, and finasteride blocks its action, thereby reducing prostate volume.

Proscar is available in tablet form and can be used by both men and women. The dosage and duration of treatment depend on the individual needs of the patient and can only be determined by a physician based on test results and medical history.

However, like any drug, Proscar has its side effects. Some of them include decreased libido, erectile dysfunction, headache, dizziness and dry mouth. In addition, finasteride may interact with other medications and cause side effects, so you should consult your doctor before starting treatment.

Overall, Proscar is an effective drug for the treatment of BPH, but its use must be strictly controlled and under the supervision of a physician.

Introduction

Proscar (Finasteride) is a medicine used to treat benign prostatic hyperplasia and to reduce the risk of prostate cancer in men over 50 years of age. The drug blocks the release of male sex hormones - androgens from prostate tissue under the action of the type 1 5α-reductase enzyme. Under the influence of Proscar, the risk of developing prostate cancer is reduced, especially tumors that arise from excess testosterone production. Reducing the risk increases the life expectancy of patients.

pharmachologic effect

Finasteride is a medicine that suppresses dihydrotestosterone, the active metabolite of testosterone, by blocking the activity of 5-α-reducing enzyme type I. The effectiveness of treatment is with an increase in PSA levels in combination with clinical regression. Reducing the risk of recurrence of PZ in patients receiving finasteride together with drugs from the hormonal therapy group (HRT). The use of Finasteride with HRT is recommended for patients with benign prostate adenoma. Use as monotherapy and combination therapy versus placebo in patients with advanced or localized adenocarcinoma. It should usually be used in conjunction with anticellular drugs